Teva says gluten challenge study succeeds in celiac disease

A single injection of an experimental antibody significantly reduced intestinal damage among people with celiac disease who then ate gluten daily, Teva Pharmaceuticals said Wednesday. The Israeli drugmaking giant reported topline ...